TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Compounded Aseptic Medicines

Pharmaceutical products
Scotland (UKM)
Published value
Not published
Submission deadline Not published
Lots published4
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS): "Compounded Aseptic Medicines". Published status: complete. Published value: Value not published. 4 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
5.2Bids / Report
10.8% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 512 active published awards; 455 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published30 Jan 2024, 15:27 GMT
Last source update30 Jan 2024, 15:27 GMT
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
Scotland (UKM)
OCIDocds-h6vhtk-0435c1
What is being bought
This Framework Agreement is for the supply of unlicensed, aseptically compounded, ready to use medicines in syringe and infusion bags to NHS Scotland.
What changed
From the official release history
  1. Status changed to complete
    30 Jan 2024, 15:27 GMT
  2. Official notice release published
    30 Jan 2024, 15:27 GMT
  3. Buyer information updated
    30 Jan 2024, 15:27 GMT
Lots and requirements (4)
Published by the contracting authority
  • Lot 1 · #1
    Compounded Aseptic Medicines
    Status not published
    Published valueNot published
    Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Atezolizumab Cetuximab Doxorubicin Epirubicin Infliximab (Inflectra®), (Remicade®), (Remsima®) Nivolumab Pembrolizumab Pertuzumab The Authority intends to awarded all presentations within this Lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Compounded Aseptic Medicines
    Status not published
    Published valueNot published
    Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Cyclophosphamide Fluorouracil Irinotecan Methotrexate Rituximab (Mabthera®), (Rixathon®), (Truxima®) The Authority intends to awarded all presentations within this Lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    Compounded Aseptic Medicines
    Status not published
    Published valueNot published
    Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Bortezomib Carboplatin Cisplatin Docetaxel Gemcitabine Oxaliplatin Trastuzumab (Herceptin®), (Herzuma®) Vincristine The Authority intends to awarded all presentations within this Lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #4
    Compounded Aseptic Medicines - All Other Presentations
    Status not published
    Published valueNot published
    upply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, The molecules included in this Lot are, Bevacizumab Cytarabine Infliximab (Zessly®) Insulin Methotrexate Natalizumab Nivolumab Paclitaxel Pemetrexed Tocilizumab Trastuzumab (Kanjinti®), (Ontruzant®) Trastuzumab Subcutaneous Vedolizumab Each product line will be treated as an individual Lot and awarded as an unranked multi-supplier framework.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    30 Jan 2024, 15:27 GMT
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Contract active
    Signed 30 Jan 2024, 00:00 GMT · £1,012,575
  7. Contract active
    Signed 30 Jan 2024, 00:00 GMT · £945,623
  8. Contract active
    Signed 30 Jan 2024, 00:00 GMT · £3,956,458
  9. Contract active
    Signed 30 Jan 2024, 00:00 GMT · £15,384,611
Commercial outcome and competition
Awards
Qualasept Limited t/a Bath ASU
Not published · Not published · active
Baxter Healthcare Ltd
Not published · Not published · active
Baxter Healthcare Ltd, ITH Pharma Limited, Qualasept Limited t/a Bath ASU
Not published · Not published · active
Baxter Healthcare Ltd
Not published · Not published · active
Contracts
Compounded Aseptic Medicines
£1,012,575 · signed 30 Jan 2024, 00:00 GMT · active
Compounded Aseptic Medicines
£945,623 · signed 30 Jan 2024, 00:00 GMT · active
Compounded Aseptic Medicines - All Other Presentations
£3,956,458 · signed 30 Jan 2024, 00:00 GMT · active
Compounded Aseptic Medicines
£15,384,611 · signed 30 Jan 2024, 00:00 GMT · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contracting authority GB-FTS-91922
View buyer profile

  • The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
    buyer

    Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, UKM, EH12 9EB
    Linda.Downie3@nhs.scot

  • Baxter Healthcare Ltd
    supplier

    Wallingford Road, Compton,, Newbury, Berkshire, UK, RG20 7QW
    +44 1635206000

  • ITH Pharma Limited
    supplier

    Unit 4 Premier Park, Premier Park Road, London, UK, NW10 7NZ
    +44 088388260

  • Qualasept Limited t/a Bath ASU
    supplier

    Unit A15 Fiveways Light Industrial Estate, Westwells Road,, Corsham, UK, SN13 9RG

  • Sheriff Court House
    reviewBody

    27 Chambers Street, Edinburgh, EH1 1LB
    edinburgh@scotcourts.gov.uk
    +44 1312252525
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThis VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015